Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q4	-- / 462.100B	--
Feb 10, 2025	2025/Q3	460.844B / 492.903B	--
Nov 7, 2024	2025/Q2	484.790B / 491.534B	--
Aug 2, 2024	2025/Q1	438.097B / 439.733B	--
May 14, 2024	2024/Q4	403.871B / 430.868B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q4-- / 462.100B--

Feb 10, 20252025/Q3460.844B / 492.903B--

Nov 7, 20242025/Q2484.790B / 491.534B--

Aug 2, 20242025/Q1438.097B / 439.733B--

May 14, 20242024/Q4403.871B / 430.868B--

Unlock Free Earnings Estimates

Open Account

Oji Holdings Earnings Reports

Oji Holdings: Summary of Financial Results for the 3rd Quarter Ending March 31, 2025 [Japanese GAAP] (Consolidated)

Feb 9 23:00 ET

Oji Holdings: Confirmation letter

Nov 13, 2024 01:50 ET

Oji Holdings: Semi-Annual Report - 101st Term (2024/04/01 - 2025/03/31)

Nov 13, 2024 01:48 ET

Oji Holdings: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (Consolidated)

Nov 6, 2024 23:00 ET

Symbol Price % Chg

D. Western Therapeutics Institute